PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

micafungin

Verify with FDA → · CMS NADAC pricing →

Brand names: Mycamine

Echinocandin Antifungal Rx

Micafungin is an antifungal medicine. It treats certain Candida infections in adults and children.

What it does

Micafungin treats several types of Candida infections.

Common side effects

Diarrhea, Nausea, Vomiting

Key warnings

Micafungin can cause serious allergic reactions, including shock.

How It Works

Micafungin stops the growth of Candida by blocking a key part of its cell wall. This weakens the fungus and allows your body to fight the infection. It targets a substance called 1,3-beta-D-glucan.

How to Take It

Micafungin is given through a vein (IV) by a healthcare provider. The dose depends on your age, weight, and the type of infection. It is usually given once a day, infused slowly over 1 hour. The typical treatment lasts for about 10-20 days.

Pregnancy & Breastfeeding

Micafungin may harm your unborn baby. Tell your doctor if you are pregnant or plan to become pregnant. It is not known if micafungin passes into breast milk. Talk to your doctor about the risks and benefits of breastfeeding.

Missed Dose

Since a healthcare provider gives you this medicine, you are not likely to miss a dose. Call your doctor if you think you missed a dose.

Storage

Unopened vials should be stored at room temperature, away from light.

Side Effects (from patient reports)

Based on 3,328 FDA adverse event reports.

The medicine is not working
985
Using the medicine for a condition it is not approved for
542
Fever
281
Using the product for a condition it is not approved for
275
Fever with low white blood cell count
258
Failure of multiple organs
213
Sudden kidney damage
204
Lung failure
193
Lung infection
190
Blood infection
187

FDA Adverse Event Report Analysis

Detailed analysis of 4,779 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

4,779

Death-Related Reports

1,712

Hospitalization Reports

2,379

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 1,706 (39%)
Male 2,648 (61%)

Age Distribution

0–17 804
18–44 975
45–64 1,260
65–74 731
75+ 340

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 DRUG INEFFECTIVE 985
2 OFF LABEL USE 542
3 PYREXIA 281
4 PRODUCT USE IN UNAPPROVED INDICATION 275
5 FEBRILE NEUTROPENIA 258
6 MULTIPLE ORGAN DYSFUNCTION SYNDROME 213
7 ACUTE KIDNEY INJURY 204
8 RESPIRATORY FAILURE 193
9 PNEUMONIA 190
10 SEPSIS 188
11 NEUTROPENIA 176
12 SEPTIC SHOCK 168
13 DIARRHOEA 167
14 CONDITION AGGRAVATED 163
15 CANDIDA INFECTION 142

Reactions in Death Reports

DRUG INEFFECTIVE 560
OFF LABEL USE 210
MULTIPLE ORGAN DYSFUNCTION SYNDROME 197
RESPIRATORY FAILURE 133
SEPTIC SHOCK 131
DEATH 126
SEPSIS 116
PNEUMONIA 109
CANDIDA INFECTION 89
CONDITION AGGRAVATED 87

Reactions in Hospitalization Reports

DRUG INEFFECTIVE 497
OFF LABEL USE 253
PYREXIA 186
FEBRILE NEUTROPENIA 185
RESPIRATORY FAILURE 134
ACUTE KIDNEY INJURY 133
MULTIPLE ORGAN DYSFUNCTION SYNDROME 127
PNEUMONIA 123
SEPSIS 118
SEPTIC SHOCK 103

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Micafungin can cause serious allergic reactions, including shock. Tell your doctor right away if you have hives, trouble breathing, or swelling. It can also cause liver problems. Your doctor will check your liver function during treatment.

Known Drug Interactions

Monitor for sirolimus, itraconazole or nifedipine toxicity, and dosage of sirolimus, itraconazole or nifedipine should be reduced, if necessary. Co-administration of Micafungin for Injection with Other Drugs Co-administration of micafungin for injection with mycophenolate mofetil (MMF), amphotericin B, tacrolimus, prednisolone, sirolimus and nifedipine did not alter the pharmacokinetics of micafungin for injection. Nifedipine AUC and C max were increased by 18% and 42%, respectively, in the presence of steady-state micafungin for injection compared with nifedipine alone.

Mechanism: Micafungin increases the amount of nifedipine in your blood by slowing down how your body processes it.

What to do: Your doctor should monitor you for nifedipine side effects and may need to reduce your nifedipine dose.

Co-administration of Micafungin for Injection with Other Drugs Co-administration of micafungin for injection with mycophenolate mofetil (MMF), amphotericin B, tacrolimus, prednisolone, sirolimus and nifedipine did not alter the pharmacokinetics of micafungin for injection. 7.2 Effect of Micafungin for Injection on Other Drug CYP3A4 Substrates There was no effect of single or multiple doses of micafungin for injection on cyclosporine, tacrolimus, prednisolone, voriconazole and fluconazole pharmacokinetics. Co-administration of Micafungin for Injection with Other Drugs Co-administration of mi...

Mechanism: These two drugs do not affect how the body breaks down or uses either medication.

What to do: No special dose changes are needed when taking these two drugs at the same time.

(7) 7.1 Effect of Other Drugs on Micafungin for Injection CYP3A4, CYP2C9 and CYP2C19 Inhibitors Co-administration of micafungin for injection with cyclosporine, itraconazole, voriconazole and fluconazole did not alter the pharmacokinetics of micafungin for injection. 7.2 Effect of Micafungin for Injection on Other Drug CYP3A4 Substrates There was no effect of single or multiple doses of micafungin for injection on cyclosporine, tacrolimus, prednisolone, voriconazole and fluconazole pharmacokinetics. 7.1 Effect of Other Drugs on Micafungin for Injection CYP3A4, CYP2C9 and CYP2C19 Inhibitors ...

Mechanism: These drugs do not change each other's levels in the bloodstream when taken together.

What to do: You can take these medications together without needing to change your dosage.

(7) 7.1 Effect of Other Drugs on Micafungin for Injection CYP3A4, CYP2C9 and CYP2C19 Inhibitors Co-administration of micafungin for injection with cyclosporine, itraconazole, voriconazole and fluconazole did not alter the pharmacokinetics of micafungin for injection. 7.2 Effect of Micafungin for Injection on Other Drug CYP3A4 Substrates There was no effect of single or multiple doses of micafungin for injection on cyclosporine, tacrolimus, prednisolone, voriconazole and fluconazole pharmacokinetics. 7.1 Effect of Other Drugs on Micafungin for Injection CYP3A4, CYP2C9 and CYP2C19 Inhibitors ...

Mechanism: Taking these two drugs together does not change the amount of either drug in your body.

What to do: No dosage adjustments are required when these medications are used together.

CYP2C19 and CYP3A4 Inducer Co-administration of micafungin for injection with rifampin and ritonavir did not alter the pharmacokinetics of micafungin for injection. CYP2C19 and CYP3A4 Inducer Co-administration of micafungin for injection with rifampin and ritonavir did not alter the pharmacokinetics of micafungin for injection.

Mechanism: Rifampin does not change how the body processes or removes micafungin.

What to do: You do not need to change your micafungin dose if you are also taking rifampin.

Check all your medications →

Common Questions

What if I am allergic to other antifungal medicines?
Tell your doctor if you are allergic to any other echinocandin antifungals. You should not take this medicine if you are allergic to micafungin.
Will micafungin interact with my other medicines?
Micafungin can interact with some medicines, like sirolimus, itraconazole, and nifedipine. Your doctor may need to adjust the dose of these medicines.
How long will I need to take micafungin?
The length of treatment depends on the type and severity of your infection. Your doctor will decide how long you need to take it. The average treatment is about 15 days.
What tests will I need while taking micafungin?
Your doctor will check your kidney and liver function with blood tests. They may also monitor your blood counts.
Can micafungin cause liver problems?
Yes, micafungin can sometimes cause liver problems. Your doctor will monitor your liver function during treatment.
What should I do if I have side effects?
Tell your doctor about any side effects you experience. They may be able to help manage them.
Can I receive vaccinations while taking micafungin?
Ask your doctor or pharmacist before getting any vaccinations while on this medicine.
Is it safe to drink alcohol while taking micafungin?
Ask your doctor if it is safe to drink alcohol while taking this medicine.
How will I know if the medicine is working?
Your doctor will monitor your condition and check for signs that the infection is improving.
What should I do if my symptoms get worse?
Tell your doctor right away if your symptoms get worse or if you develop new symptoms.
What are the common side effects of micafungin?
The most commonly reported side effects of micafungin include Diarrhea, Nausea, Vomiting, Abdominal pain, Fever. Based on 3,328 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does micafungin interact with other medications?
Yes, micafungin has 8 known drug interactions. Notable interactions include nifedipine, prednisolone, fluconazole. Always inform your doctor about all medications you are taking.
What drug class is micafungin?
micafungin belongs to the Echinocandin Antifungal drug class. It requires a prescription (Rx). Micafungin treats several types of Candida infections.
Is micafungin safe during pregnancy?
Micafungin may harm your unborn baby. Tell your doctor if you are pregnant or plan to become pregnant. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.
Has micafungin been recalled?
There is 1 recall associated with micafungin products. Cross contamination with other products. Check the recalls section below for full details and affected products.

Active Recalls

Class III July 2, 2024

Cross contamination with other products

Zydus Pharmaceuticals (USA) Inc

Related Medications in Echinocandin Antifungal

Other drugs grouped near micafungin — same-class peers and common alternatives.

Compare micafungin vs acyclovir side-by-side →

Medication Guides

Related Health & Safety Data

Save on micafungin

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for micafungin

The FDA label for micafungin (sold under brand names such as Mycamine) classifies it as a prescription-only medication in the Echinocandin Antifungal class. Micafungin treats several types of Candida infections. Official labeling lists 8 commonly reported side effects, including Diarrhea, Nausea, Vomiting.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 3,328 voluntary reports. The database also lists 8 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated minor severity. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 1 recall record on file), and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: December 17, 2025

All federal data sources used on this page